H.R. 1816: Ovarian Cancer Biomarker Research Act of 2009
H.R. 1816: Ovarian Cancer Biomarker Research Act of 2009
A bill in the U.S. Congress: To amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer.
Results for bill H.R. 1816: Ovarian Cancer Biomarker Research Act of 2009
No media matches
- Sponsor: Howard L. Berman
- Introduced: Mar 31, 2009
- Bill Profile on Open Congress
- Bill Funding Profile on MAPLight
Cosponsors
- Cosponsor: Madeleine Z. Bordallo, Peter T. King, Dennis J. Kucinich, Jerrold Nadler, Mark Green, James P. McGovern, Yvette Clarke, Debbie Wasserman Schultz, Sam Farr, Ralph M. Hall, John M. McHugh, Dan Burton, Jim McDermott, Rosa L. DeLauro, Barbara Lee, Steve Israel, Carolyn B. Maloney, Maurice D. Hinchey, Joe Sestak, José E. Serrano, Chris Van Hollen, Rick Boucher, Carol Shea-Porter, Lois Capps, Frank R. Wolf
